Company News: LVLT, GLBC, ENDP, AMMD, AA, MCP, JPM, BHP, FLO, TSTY, BIIB, THC, CYH

• Level 3 Communications (NASDAQ:LVLT) and Global Crossing Limited (NASDAQ:GLBC) have entered into a agreement under which Level 3 will acquire Global Crossing in a stock-for-stock transaction

• Endo Pharmaceuticals’ (NASDAQ:ENDP) said that it would buy urological medical device supplier American Medical Systems (NASDAQ:AMMD) for about $2.6 billion

• Alcoa (NYSE:AA) reported Q1 EPS of $0.28, ex-items, ahead of the Zacks Consensus Estimate of $0.27 per share. Revenues for the quarter rose 22% year-over-year to $6.0 billion, lower than the Zacks Consensus Estimate of $6.112 billion

• Share prices of Molycorp, Inc. (NYSE:MCP) increased 5% after JP Morgan (NYSE:JPM) raised its target price to $90 from $74

• Credit Suisse upgraded BHP Billiton (NYSE:BHP) to ‘Outperform’ from ‘Neutral’ rating. Share prices of BHP Billiton gained 1.34% to close at $102.68

• Flowers Food Inc. (NYSE:FLO) said it would pay $4 a share, or $34.4 million, for the packaged-sweets manufacturer Tasty Baking Co (NASDAQ:TSTY)

• Biotechnology company Biogen Idec Inc. (NASDAQ:BIIB) reported that its experimental multiple-sclerosis drug showed promising results in two late stage studies

• Tenet Healthcare Corp.(NYSE:THC) has filed a lawsuit against Community Health Systems Inc. (NYSE:CYH) claiming its rival hospital operator had improperly admitted patients to benefit financially.

TASTY BAKING (TSTY): Free Stock Analysis Report

© 2016 Wallstreetpit.com. Wall Street Pit does not provide investment advice. Please take a moment to read through our Terms of Use. All rights reserved.
About Zacks Investment Research 1767 Articles

Zacks Investment Research is one of the most highly regarded firms in the investment industry. In 1978 Zacks originated the concept of utilizing earnings estimates revisions to make profitable investment decisions. Zacks offers multiple investment products and services to help investors achieve superior returns.

Visit: Zacks.com

Be the first to comment

Leave a Reply

Your email address will not be published.


*